AAAAAA
Results:
1-18
|
Results: 18
Authors:
Bristow, RE
Montz, FJ
Citation: Re. Bristow et Fj. Montz, Leiomyomatosis peritonealis disseminata and ovarian Brenner tumor associated with tamoxifen use, INT J GYN C, 11(4), 2001, pp. 312-315
Authors:
Shipman, SD
Bristow, RE
Citation: Sd. Shipman et Re. Bristow, Adenocarcinoma in situ and early invasive adenocarcinoma of the uterine cervix, CURR OPIN O, 13(5), 2001, pp. 394-398
Authors:
Bristow, RE
Montz, FJ
Citation: Re. Bristow et Fj. Montz, Complete surgical cytoreduction of advanced ovarian carcinoma using the argon beam coagulator, GYNECOL ONC, 83(1), 2001, pp. 39-48
Authors:
Bristow, RE
Sehdev, AES
Kaufman, HS
Montz, FJ
Citation: Re. Bristow et al., Ablation of metastatic ovarian carcinoma with the argon beam coagulator: Pathologic analysis of tumor destruction, GYNECOL ONC, 83(1), 2001, pp. 49-55
Authors:
Bristow, RE
Asrari, F
Trimble, EL
Montz, FJ
Citation: Re. Bristow et al., Extended surgical staging for uterine papillary serous carcinoma: Survivaloutcome of locoregional (Stage I-III) disease, GYNECOL ONC, 81(2), 2001, pp. 279-286
Authors:
Bristow, RE
Duska, LR
Montz, FJ
Citation: Re. Bristow et al., The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma, GYNECOL ONC, 81(1), 2001, pp. 92-99
Authors:
Montz, FJ
Farber, FL
Bristow, RE
Cornelison, T
Citation: Fj. Montz et al., Impact of increasing Papanicolaou test sensitivity and compliance: A modeled cost and outcomes analysis, OBSTET GYN, 97(5), 2001, pp. 781-788
Authors:
Bristow, RE
Citation: Re. Bristow, Surgical standards in the management of ovarian cancer, CURR OPIN O, 12(5), 2000, pp. 474-480
Authors:
Bovicelli, A
Bristow, RE
Montz, FJ
Citation: A. Bovicelli et al., HPV testing: Where are we now?, ANTICANC R, 20(6C), 2000, pp. 4673-4680
Authors:
Nguyen, CP
Levi, AW
Montz, FJ
Bristow, RE
Citation: Cp. Nguyen et al., Coexistent choriocarcinoma and malignant mixed mesodermal tumor of the uterus, GYNECOL ONC, 79(3), 2000, pp. 499-503
Authors:
Zerbe, MJ
Zhang, JY
Bristow, RE
Grumbine, FC
Abularach, S
Montz, FJ
Citation: Mj. Zerbe et al., Retrograde seeding of malignant cells during hysteroscopy in presumed early endometrial cancer, GYNECOL ONC, 79(1), 2000, pp. 55-58
Authors:
Bristow, RE
Zerbe, MJ
Rosenshein, NB
Grumbine, FC
Montz, FJ
Citation: Re. Bristow et al., Stage IVB endometrial carcinoma: The role of cytoreductive surgery and determinants of survival, GYNECOL ONC, 78(2), 2000, pp. 85-91
Authors:
Nguyen, C
Montz, FJ
Bristow, RE
Citation: C. Nguyen et al., Management of stage I cervical cancer in pregnancy, OB GYN SURV, 55(10), 2000, pp. 633-643
Authors:
Bristow, RE
Duska, LR
Lambrou, NC
Fishman, EK
O'Neill, MJ
Trimble, EL
Montz, FJ
Citation: Re. Bristow et al., A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography, CANCER, 89(7), 2000, pp. 1532-1540
Authors:
Chin, AB
Bristow, RE
Korst, LM
Walts, A
Lagasse, LD
Citation: Ab. Chin et al., The significance of atypical glandular cells on routine cervical cytologictesting in a community-based population, AM J OBST G, 182(6), 2000, pp. 1278-1282
Authors:
del Carmen, MG
Montz, FJ
Bristow, RE
Bovicelli, A
Cornelison, T
Trimble, E
Citation: Mg. Del Carmen et al., Ethnic differences in patterns of care of stage 1A(1) and stage 1A(2) cervical cancer: A SEER database study, GYNECOL ONC, 75(1), 1999, pp. 113-117
Authors:
Bristow, RE
Montz, FJ
Lagasse, LD
Leuchter, RS
Karlan, BY
Citation: Re. Bristow et al., Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer, GYNECOL ONC, 72(3), 1999, pp. 278-287
Authors:
Bristow, RE
Baldwin, RL
Yamada, SD
Korc, M
Karlan, BY
Citation: Re. Bristow et al., Altered expression of transforming growth factor-beta ligands and receptors in primary and recurrent ovarian carcinoma, CANCER, 85(3), 1999, pp. 658-668
Risultati:
1-18
|